Patents by Inventor Robbert Hans Meloen

Robbert Hans Meloen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8748105
    Abstract: The invention relates to the field of candidate drug testing and drug development. A method is provided for providing a compound composed of at least one molecule attached via at least two linkages to a molecular scaffold, the method comprising providing a scaffold comprising at least a first and a second reactive group; providing at least one molecule capable of reacting with the at least first and second reactive group; contacting the scaffold with at least one molecule to form at least two linkages between the scaffold and the at least one molecule in a coupling reaction, wherein the formation of a linkage accelerates the formation of a consecutive linkage, preferably wherein the coupling reaction is performed in solution, more preferably in an aqueous solution. Furthermore, a method is provided for selecting a candidate drug compound comprising providing a library of compounds according to the invention and determining the binding of a target molecule to the compounds.
    Type: Grant
    Filed: August 26, 2005
    Date of Patent: June 10, 2014
    Assignee: Pepscan Systems B.V.
    Inventors: Peter Timmerman, Joris Beld, Robbert Hans Meloen, Wouter Cornelis Puijk
  • Patent number: 8742070
    Abstract: The disclosure relates to the field of candidate drug testing and drug development. Described are methods for providing a compound composed of at least one molecule attached via at least two linkages to a molecular scaffold, the method comprising providing a scaffold comprising at least a first and a second reactive group; providing at least one molecule able to react with the at least first and second reactive group; and contacting the scaffold with at least one molecule to form at least two linkages between the scaffold and the molecule in a coupling reaction, wherein the formation of a linkage accelerates the formation of a consecutive linkage. The coupling reaction may be performed in solution, such as an aqueous solution. Furthermore, described is a method for selecting a candidate drug compound comprising providing a library of the compounds and determining the binding of a target molecule to the compounds.
    Type: Grant
    Filed: April 10, 2012
    Date of Patent: June 3, 2014
    Assignee: Pepscan Systems B.V.
    Inventors: Peter Timmerman, Joris Beld, Robbert Hans Meloen, Wouter Cornelis Puijk
  • Publication number: 20130158232
    Abstract: The disclosure relates to the field of candidate drug testing and drug development. Described are methods for providing a compound composed of at least one molecule attached via at least two linkages to a molecular scaffold, the method comprising providing a scaffold comprising at least a first and a second reactive group; providing at least one molecule able to react with the at least first and second reactive group; and contacting the scaffold with at least one molecule to form at least two linkages between the scaffold and the molecule in a coupling reaction, wherein the formation of a linkage accelerates the formation of a consecutive linkage. The coupling reaction may be performed in solution, such as an aqueous solution. Furthermore, described is a method for selecting a candidate drug compound comprising providing a library of the compounds and determining the binding of a target molecule to the compounds.
    Type: Application
    Filed: April 10, 2012
    Publication date: June 20, 2013
    Inventors: Peter TIMMERMAN, Joris Beld, Robbert Hans Meloen, Wouter Cornelis Puijk
  • Patent number: 7972993
    Abstract: The invention relates to the field of molecular recognition or detection of discontinuous or conformational binding sites or epitopes corresponding to a binding molecule, in particular, in relation to protein-protein, protein-nucleic acid, nucleic acid-nucleic acid or biomolecule-ligand interactions. The invention provides a synthetic molecular library allowing testing for, identification, characterization or detection of a discontinuous binding site capable of interacting with a binding molecule, the library having been provided with a plurality of test entities, each test entity comprising at least one first segment spotted next to a second segment, each segment having the capacity of being a potential single part of a discontinuous binding site.
    Type: Grant
    Filed: April 10, 2003
    Date of Patent: July 5, 2011
    Assignee: Pepscan Systems B.V.
    Inventors: Jelle Wouter Slootstra, Wouter Cornelis Puijk, Robbert Hans Meloen, Pieter van Dijken, Evert van Dijk
  • Patent number: 7863239
    Abstract: The invention provides means and methods for producing compounds suitable for testing for the presence and/or identification of an immunogenic compound and/or a binding compound of interest. Immunogenic compounds and compositions are also herewith provided, as well as peptidomimetics of members of the cystine-knot family.
    Type: Grant
    Filed: January 24, 2006
    Date of Patent: January 4, 2011
    Assignee: Pepscan Systems B.V.
    Inventors: Peter Timmerman, Wouter Cornelis Puijk, Jelle Wouter Slootstra, Evert van Dijk, Robbert Hans Meloen
  • Publication number: 20100322945
    Abstract: The invention provides means and methods for inducing and/or enhancing immunogenic reproducibility and/or immunogenicity of a compound, comprising at least in part restricting the conformation of said compound. The conformation is preferably restricted by the formation of at least one internal bond within said compound. Protein mimics comprising an amino acid sequence bound to a scaffold and/or a carrier, wherein said amino acid sequence comprises at least one internal SS-bridge, are also herewith provided.
    Type: Application
    Filed: July 26, 2007
    Publication date: December 23, 2010
    Inventors: Peter Timmerman, Wouter Cornelis Puijk, Robbert Hans Meloen
  • Publication number: 20030226169
    Abstract: The present invention provides DNA sequences encoding antifungal peptides which comprise at least six amino acid residues identical to a run of amino acid residues found between position 21 and position 51 of the Rs-AFP2 antifungal protein sequence (SEQ ID NO: 35) or a substantially homologous protein.
    Type: Application
    Filed: March 13, 2003
    Publication date: December 4, 2003
    Inventors: Aart Van Amerongen, Franky Fant, Frans Alois Melania Borremans, Genoveva Wivina De Samblanx, Lolke Sijtsma, Robbert Hans Meloen, Wouter Cornelis Puijk, Wilhelmus Martinus Maria Schaaper, Willem Frans Broekaert, Wilhelmus Martinus Jozef Van Gelder, Sarah Bronwen Rees
  • Patent number: 6605698
    Abstract: Antifungal peptides which comprise at least six amino acid residues identical to a run of amino acid residues found between position 21 and position 51 of the Rs-AFP2 antifungal protein sequence or of substantially homologous protein sequences. The peptides are useful for combating fungal diseases in agricultural, pharmaceutical or preservative applications.
    Type: Grant
    Filed: August 7, 1998
    Date of Patent: August 12, 2003
    Assignee: Syngenta Limited
    Inventors: Aart Van Amerongen, Franky Fant, Frans Alois Borremans, Genoveva Wivina De Samblanx, Lolke Sijtsma, Robbert Hans Meloen, Wouter Cornelis Puijk, Wilhelmus Martinus Maria Schaaper, Willem Frans Broekaert, Wilhelmus Martinus Josef van Gelder, Sarah Bronwen Rees
  • Publication number: 20010021513
    Abstract: A test device comprises a plate containing a multiplicity of wells and an associated metering device suitable for simultaneously introducing equal volumes of reagent into different wells of the test device. The test device comprises wells which have a volume within the range of 0.1-20 &mgr;l. The ratio between the depth of the wells and the diameter is preferably less than 1:1. The test device according to the invention can be used for carrying out the bio- or immuno-chemical test such as a pepscan or ELISA.
    Type: Application
    Filed: January 5, 2001
    Publication date: September 13, 2001
    Inventors: Wouter Cornelis Puijk, Gerard Johannes Ligtvoet, Robbert Hans Meloen